Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $24.5 Million - $30.8 Million
1,402,294 New
1,402,294 $29 Million
Q4 2023

Feb 09, 2024

BUY
$10.95 - $17.32 $20 Million - $31.6 Million
1,825,307 New
1,825,307 $26.3 Million
Q3 2023

Nov 13, 2024

BUY
$16.59 - $23.77 $28.7 Million - $41.1 Million
1,728,807 New
1,728,807 $30 Million
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $25.6 Million - $36.6 Million
-1,540,358 Closed
0 $0
Q2 2023

Aug 14, 2024

BUY
$19.27 - $24.63 $10.1 Million - $12.9 Million
524,260 Added 37.39%
1,926,554 $40.1 Million
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $23.5 Million - $30 Million
-1,218,301 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$21.42 - $32.08 $39 Million - $58.4 Million
1,821,802 New
1,821,802 $42.8 Million
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $34 Million - $41.7 Million
1,459,049 New
1,459,049 $40.8 Million
Q3 2022

Nov 13, 2023

BUY
$23.4 - $34.25 $36 Million - $52.8 Million
1,540,358 New
1,540,358 $36 Million
Q2 2022

Aug 14, 2023

BUY
$31.66 - $38.9 $38.6 Million - $47.4 Million
1,218,301 New
1,218,301 $41.1 Million
Q1 2022

May 12, 2023

BUY
$30.45 - $39.36 $1.41 Million - $1.82 Million
46,278 Added 3.17%
1,505,327 $52.6 Million
Q1 2022

May 09, 2022

SELL
$30.45 - $39.36 $60.1 Million - $77.7 Million
-1,974,938 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$28.67 - $37.13 $56.6 Million - $73.3 Million
1,974,938 New
1,974,938 $60.1 Million
Q3 2021

Nov 14, 2022

BUY
$28.63 - $35.64 $77.7 Million - $96.7 Million
2,713,237 New
2,713,237 $89 Million
Q3 2021

Nov 05, 2021

SELL
$28.63 - $35.64 $74.1 Million - $92.3 Million
-2,589,910 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$28.45 - $38.0 $73.7 Million - $98.4 Million
2,589,910 New
2,589,910 $78.4 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.